Stay updated on Upadacitinib in Active Ankylosing Spondylitis Clinical Trial

Sign up to get notified when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-08T03:35:47.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2 in the page footer. No changes to study details, eligibility criteria, locations, or outcomes.
    Difference
    0.0%
    Check dated 2026-02-14T12:59:18.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.4.1 replaces v3.4.0 on the page, a minor UI/version-tracking update with no changes to study content.
    Difference
    0.0%
    Check dated 2026-02-07T07:29:15.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    UI/metadata changes include adding a 'Show glossary' option, updating the label to 'Last Update Submitted that Met QC Criteria', capitalizing 'No FEAR Act Data', and changing the revision from v3.3.4 to v3.4.0. These updates do not alter core study content, eligibility, outcomes, or locations.
    Difference
    0.1%
    Check dated 2026-01-24T02:13:51.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Revision: v3.3.4 applied to the page (replacing v3.3.3).
    Difference
    0.0%
    Check dated 2026-01-17T01:08:06.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Difference
    3%
    Check dated 2025-12-19T10:22:30.000Z thumbnail image

Stay in the know with updates to Upadacitinib in Active Ankylosing Spondylitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Upadacitinib in Active Ankylosing Spondylitis Clinical Trial page.